$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
CDK4/6抑制剂瑞博西林多少钱一盒?国内能买到吗?
2025-10-19 11:44:20
Check Details
CDK4/6抑制剂瑞博西利给乳腺癌晚期带来了哪些好处?
2025-10-19 11:44:20
Check Details
瑞博西林是治疗HR+/HER2-绝经后晚期乳腺癌的口服抗癌靶向药
2025-10-19 11:44:20
Check Details
CDK4/6抑制剂瑞博西利治疗乳腺癌晚期的效果显著
2025-10-19 11:44:20
Check Details
奥拉帕利治疗HER2阴性转移性乳腺癌的安全性和耐受性
2025-10-19 11:44:20
Check Details
瑞博西林可有效提高HR+/HER2-绝经前晚期乳腺癌患者生存期
2025-10-19 11:44:20
Check Details
乳腺癌患者服用爱博新进行治疗能活多久?
2025-10-19 11:44:20
Check Details
奥拉帕利可以用于治疗三阴性乳腺癌患者吗?
2025-10-19 11:44:20
Check Details
瑞博西林的出现,使绝经前晚期乳腺癌患者获益
2025-10-19 11:44:20
Check Details
三阴性乳腺癌可以使用爱博新进行治疗吗?
2025-10-19 11:44:20
Check Details
瑞博西林对晚期乳腺癌有着不错的效果
2025-10-19 11:44:20
Check Details
奥拉帕利是乳腺癌的一线维持治疗用药吗?
2025-10-19 11:44:20
Check Details
1
2
...
8052
8053
8054
8055
8056
8057
8058
...
10210
10211
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Pazopanib Shows Promise as Second-Line Therapy for Aggressive Skin Cancer
2
Opicapone Contraindications: Essential Restrictions for At-Risk Groups
3
Finerenone: An Innovative Treatment for Diabetic Kidney Disease
4
Managing Immunotherapy-Related Adverse Events of Tarlatamab-Imdelltra: A Guide to Dual-Specific T Cell Engager Safety
5
Almonertinib Safety Guide: Managing Adverse Reactions in NSCLC Treatment with a 3rd-Gen EGFR TKI
6
Pimitespib Storage Guidelines: Temperature, Humidity & Light Control for Home Use
7
Sirolimus (Rapamune) Comprehensive Clinical Guide
8
Lusutrombopag Efficacy, Dosage and Storage Instructions
9
Icotyde (Icotrokinra) Side Effects, Pharmacokinetics and Storage Instructions
10
Cemiplimab (Libtayo) Drug Information
11
Enfortumab Vedotin (Padcev): Nectin-4-Targeted ADC for Advanced Urothelial Carcinoma
12
Urece (Dotinurad): Highly Selective URAT1 Inhibitor for Gout and Hyperuricemia